148 related articles for article (PubMed ID: 25935488)
1. Anti-arthritis effect of a novel quinazoline derivative through inhibiting production of TNF-α mediated by TNF-α converting enzyme in murine collagen-induced arthritis model.
Pu Y; Cao D; Xie C; Pei H; Li D; Tang M; Chen L
Biochem Biophys Res Commun; 2015 Jul; 462(4):288-93. PubMed ID: 25935488
[TBL] [Abstract][Full Text] [Related]
2. Characterization of (2R, 3S)-2-([[4-(2-butynyloxy)phenyl]sulfonyl]amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-alpha converting enzyme.
Zhang Y; Hegen M; Xu J; Keith JC; Jin G; Du X; Cummons T; Sheppard BJ; Sun L; Zhu Y; Rao VR; Wang Q; Xu W; Cowling R; Nickerson-Nutter CL; Gibbons J; Skotnicki J; Lin LL; Levin J
Int Immunopharmacol; 2004 Dec; 4(14):1845-57. PubMed ID: 15531300
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.
Zhang Y; Xu J; Levin J; Hegen M; Li G; Robertshaw H; Brennan F; Cummons T; Clarke D; Vansell N; Nickerson-Nutter C; Barone D; Mohler K; Black R; Skotnicki J; Gibbons J; Feldmann M; Frost P; Larsen G; Lin LL
J Pharmacol Exp Ther; 2004 Apr; 309(1):348-55. PubMed ID: 14718605
[TBL] [Abstract][Full Text] [Related]
4. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
5. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of DPC 333 ((2R)-2-((3R)-3-amino-3{4-[2-methyl-4-quinolinyl) methoxy] phenyl}-2-oxopyrrolidinyl)-N-hydroxy-4-methylpentanamide)), a potent and selective inhibitor of tumor necrosis factor alpha-converting enzyme in rodents, dogs, chimpanzees, and humans.
Qian M; Bai SA; Brogdon B; Wu JT; Liu RQ; Covington MB; Vaddi K; Newton RC; Fossler MJ; Garner CE; Deng Y; Maduskuie T; Trzaskos J; Duan JJ; Decicco CP; Christ DD
Drug Metab Dispos; 2007 Oct; 35(10):1916-25. PubMed ID: 17656469
[TBL] [Abstract][Full Text] [Related]
7. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
8. Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment.
Rioja I; Bush KA; Buckton JB; Dickson MC; Life PF
Clin Exp Immunol; 2004 Jul; 137(1):65-73. PubMed ID: 15196245
[TBL] [Abstract][Full Text] [Related]
9. Blockade of tumor necrosis factor-α converting enzyme (TACE) enhances IL-1β and IFN-γ via caspase-1 activation: a probable cause for loss of efficacy of TACE inhibitors in humans?
Sharma M; Mohapatra J; Acharya A; Deshpande SS; Chatterjee A; Jain MR
Eur J Pharmacol; 2013 Feb; 701(1-3):106-13. PubMed ID: 23266381
[TBL] [Abstract][Full Text] [Related]
10. Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.
Ross SE; Williams RO; Mason LJ; Mauri C; Marinova-Mutafchieva L; Malfait AM; Maini RN; Feldmann M
J Immunol; 1997 Dec; 159(12):6253-9. PubMed ID: 9550429
[TBL] [Abstract][Full Text] [Related]
11. Differential effects between marimastat, a TNF-alpha converting enzyme inhibitor, and anti-TNF-alpha antibody on murine models for sepsis and arthritis.
Tsuji F; Oki K; Okahara A; Suhara H; Yamanouchi T; Sasano M; Mita S; Horiuchi M
Cytokine; 2002 Mar; 17(6):294-300. PubMed ID: 12061836
[TBL] [Abstract][Full Text] [Related]
12. Morus bombycis Koidzumi extract suppresses collagen-induced arthritis by inhibiting the activation of nuclear factor-κB and activator protein-1 in mice.
Kim HS; Kim AR; Park HJ; Park DK; Kim DK; Ko NY; Kim B; Choi DK; Won HS; Shin WS; Kim YM; Choi WS
J Ethnopharmacol; 2011 Jul; 136(3):392-8. PubMed ID: 21251971
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of hyaluronan degradation reduced pro-inflammatory cytokines in mouse synovial fibroblasts subjected to collagen-induced arthritis.
Campo GM; Avenoso A; D'Ascola A; Scuruchi M; Prestipino V; Nastasi G; Calatroni A; Campo S
J Cell Biochem; 2012 Jun; 113(6):1852-67. PubMed ID: 22234777
[TBL] [Abstract][Full Text] [Related]
14. THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis.
Tomita T; Kakiuchi Y; Tsao PS
Arthritis Res Ther; 2006; 8(1):R7. PubMed ID: 16356194
[TBL] [Abstract][Full Text] [Related]
15. P-selectin glycoprotein ligand 1 therapy ameliorates established collagen-induced arthritis in DBA/1 mice partly through the suppression of tumour necrosis factor.
Sumariwalla PF; Malfait AM; Feldmann M
Clin Exp Immunol; 2004 Apr; 136(1):67-75. PubMed ID: 15030516
[TBL] [Abstract][Full Text] [Related]
16. A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis.
Saito H; Kojima T; Takahashi M; Horne WC; Baron R; Amagasa T; Ohya K; Aoki K
Arthritis Rheum; 2007 Apr; 56(4):1164-74. PubMed ID: 17393436
[TBL] [Abstract][Full Text] [Related]
17. Eupatilin ameliorates collagen induced arthritis.
Kim J; Kim Y; Yi H; Jung H; Rim YA; Park N; Jung SM; Park SH; Ju JH
J Korean Med Sci; 2015 Mar; 30(3):233-9. PubMed ID: 25729243
[TBL] [Abstract][Full Text] [Related]
18. Anti-arthritic effect of ginsenoside Rb1 on collagen induced arthritis in mice.
Kim HA; Kim S; Chang SH; Hwang HJ; Choi YN
Int Immunopharmacol; 2007 Oct; 7(10):1286-91. PubMed ID: 17673143
[TBL] [Abstract][Full Text] [Related]
19. Suppression of tumour necrosis factor production from mononuclear cells by a novel synthetic compound, CLX-090717.
Sumariwalla PF; Palmer CD; Pickford LB; Feldmann M; Foxwell BM; Brennan FM
Rheumatology (Oxford); 2009 Jan; 48(1):32-8. PubMed ID: 19015145
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases.
Conway JG; Andrews RC; Beaudet B; Bickett DM; Boncek V; Brodie TA; Clark RL; Crumrine RC; Leenitzer MA; McDougald DL; Han B; Hedeen K; Lin P; Milla M; Moss M; Pink H; Rabinowitz MH; Tippin T; Scates PW; Selph J; Stimpson SA; Warner J; Becherer JD
J Pharmacol Exp Ther; 2001 Sep; 298(3):900-8. PubMed ID: 11504783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
